According to Amicus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -5.44%. At the end of 2024 the company had an Operating Margin of 3.95%.
Year | Operating Margin | Change |
---|---|---|
2024 | 3.95% | -115.76% |
2023 | -25.03% | -59.79% |
2022 | -62.24% | -9.05% |
2021 | -68.44% | -29.1% |
2020 | -96.53% | -47.81% |
2019 | -184.94% | -48.34% |
2018 | -358.03% | -69.38% |
2017 | -1,169.46% | -70.77% |
2016 | -4,001.27% | |
2014 | -5,600.90% | -67.78% |
2013 | -17,382.64% | 6061.45% |
2012 | -282.12% | 26.26% |
2011 | -223.44% | -96.31% |
2010 | -6,053.69% | 61849.95% |
2009 | -9.77% | -96.26% |
2008 | -261.49% | -89.82% |
2007 | -2,567.54% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.